In the 2010 study from rural West Bengal, VCTE and liver biopsy was done only on those with NAFLD diagnosed by ultrasound or CT scan with raised ALT levels (2.3% of the sample). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.